APA (7th ed.) Citation

K, T., M, H., E, F., J, I., Y, B., M, M., . . . K, Y. (2025). Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy. International journal of cancer, 157(5), 993. https://doi.org/10.1002/ijc.35472

Chicago Style (17th ed.) Citation

K, Tajima, et al. "Combination Therapy with Levofloxacin and the Probiotic Clostridium Butyricum MIYAIRI 588 Enhances Immune Checkpoint Inhibitor Efficacy." International Journal of Cancer 157, no. 5 (2025): 993. https://doi.org/10.1002/ijc.35472.

MLA (9th ed.) Citation

K, Tajima, et al. "Combination Therapy with Levofloxacin and the Probiotic Clostridium Butyricum MIYAIRI 588 Enhances Immune Checkpoint Inhibitor Efficacy." International Journal of Cancer, vol. 157, no. 5, 2025, p. 993, https://doi.org/10.1002/ijc.35472.